Difference between revisions of "2.16.840.1.113883.10.22.3.1/hgraph"

From HL7 IPS
Jump to: navigation, search
(Automated ADBot page content)
(Automated ADBot page content)
Line 30: Line 30:
 
                                 </li>
 
                                 </li>
 
                                 <li class="ad-template">
 
                                 <li class="ad-template">
−
                                     <div class="nowrapinline ad-templatetype cdaentrylevel"> Entry</div> IPS Medication Entry (2.16.840.1.113883.10.22.4.4)<ol>
+
                                     <div class="nowrapinline ad-templatetype cdaentrylevel"> Entry</div> IPS Medication Statement (2.16.840.1.113883.10.22.4.4)<ol>
 
                                         <li class="ad-template">
 
                                         <li class="ad-template">
−
                                             <div class="nowrapinline ad-templatetype cdaentrylevel"> Entry</div> IPS ManufacturedProduct (2.16.840.1.113883.10.22.4.2)<ol>
+
                                            <div class="nowrapinline ad-templatetype cdaentrylevel"> Entry</div> UV Use Period (2.16.840.1.113883.10.21.9.1)</li>
 +
                                        <li class="ad-template">
 +
                                             <div class="nowrapinline ad-templatetype cdaentrylevel"> Entry</div> IPS Medication Information (detail) (2.16.840.1.113883.10.22.4.2)<ol>
 
                                                 <li class="ad-template">
 
                                                 <li class="ad-template">
 
                                                     <div class="nowrapinline ad-templatetype cdaentrylevel"> Entry</div> IPS Manufactured Material (2.16.840.1.113883.10.22.4.3)</li>
 
                                                     <div class="nowrapinline ad-templatetype cdaentrylevel"> Entry</div> IPS Manufactured Material (2.16.840.1.113883.10.22.4.3)</li>

Revision as of 10:55, 2 July 2018

  1. Section
     IPS Medication Summary Section (2.16.840.1.113883.10.22.3.1)
    1. Entry
       IPS Body Author (2.16.840.1.113883.10.22.4.14)
      1. Entry
         IPS CDA Device (2.16.840.1.113883.10.22.9.2)
    2. Entry
       CDA Informant (Body) (2.16.840.1.113883.10.12.319)
      1. *
         CDA AssignedEntity (2.16.840.1.113883.10.12.153)
        1. *
           CDA Person (2.16.840.1.113883.10.12.152)
        2. *
           CDA Organization (2.16.840.1.113883.10.12.151)
      2. Entry
         CDA RelatedEntity (2.16.840.1.113883.10.12.316)
        1. *
           CDA Person (2.16.840.1.113883.10.12.152)
    3. Entry
       IPS Medication Statement (2.16.840.1.113883.10.22.4.4)
      1. Entry
         UV Use Period (2.16.840.1.113883.10.21.9.1)
      2. Entry
         IPS Medication Information (detail) (2.16.840.1.113883.10.22.4.2)
        1. Entry
           IPS Manufactured Material (2.16.840.1.113883.10.22.4.3)
      3. Entry
         IPS Body Author (2.16.840.1.113883.10.22.4.14)
        1. Entry
           IPS CDA Device (2.16.840.1.113883.10.22.9.2)
      4. Entry
         IPS Subordinate SubstanceAdministration (2.16.840.1.113883.10.22.4.33)
    4. Section
       IPS Translation Section (2.16.840.1.113883.10.22.3.15)
Retrieved from "http://wiki.international-patient-summary.net/index.php?title=2.16.840.1.113883.10.22.3.1/hgraph&oldid=5133"